Karen Hurley, Lisa R. Rubin, Allison Werner-Lin, Michal Sagi, Yelena Kemel, Rikki Stern, Aliza Phillips, Ina Cholst, Noah Kauff and Kenneth Offit Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations Cancer 118
Version of Record online: 26 JUN 2012 | DOI: 10.1002/cncr.27695
A total of 33 participants in the current study who were BRCA1/2 mutation carriers and were of reproductive age and had previously undergone genetic counseling viewed a tutorial regarding PGD. The majority of individuals indicated that they preferred to be briefly informed of the availability of information regarding preimplantation genetic diagnosis (PGD), and to receive written materials concerning PGD, but with the option of deferring detailed discussion if they already believed themselves to be overloaded or perceived that PGD was not immediately relevant to their risk management and/or childbearing plans. Providers offering cancer genetic testing can consider indicating that PGD information is available, while attending to the patients' level of interest and ability to absorb information.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field